Analysis of false positive PI-RADS 4 lesions: experience from a single nonacademic center using cognitive fusion-Reference-Cited by-同舟云学术

Analysis of false positive PI-RADS 4 lesions: experience from a single nonacademic center using cognitive fusion

Published:2023-02-18 Issue:5 Volume:55 Page:1081-1085
ISSN:1573-2584
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

de Souza Bianca Carla Azevedo,Novaes Marco Antonio Soares,de Souza Maiara Ferreira,do Amaral Maria Estela Pompeu,Mota Augusto,Athanazio Daniel Abensur^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

https://link.springer.com/content/pdf/10.1007/s11255-023-03508-1.pdf

Reference14 articles.

1. Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R et al (2017) PROMIS study group. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389:815–822. https://doi.org/10.1016/S0140-6736(16)32401-1

2. Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH (2018) PRECISION study group collaborators. mri-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378:1767–1777. https://doi.org/10.1056/NEJMoa1801993

3. Ahdoot M, Wilbur AR, Reese SE, Lebastchi AH, Mehralivand S, Gomella PT et al (2020) MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis. N Engl J Med 382:917–928. https://doi.org/10.1056/NEJMoa1910038

4. Stolk TT, de Jong IJ, Kwee TC, Luiting HB, Mahesh SVK, Doornweerd BHJ et al (2019) False positives in PIRADS (V2) 3, 4, and 5 lesions: relationship with reader experience and zonal location. Abdom Radiol (NY) 44:1044–1051. https://doi.org/10.1007/s00261-019-01919-2

5. Rouvière O, Puech P, Renard-Penna R, Claudon M, Roy C, Mège-Lechevallier F,: MRI-FIRST Investigators, et al (2019) Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol 20:100–109. https://doi.org/10.1016/S1470-2045(18)30569-2

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a novel nomogram to avoid unnecessary biopsy in patients with PI-RADS category ≥ 4 lesions and PSA ≤ 20 ng/ml;World Journal of Urology;2024-08-23